Acuta Capital Partners’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.75M | Buy |
179,569
+53,861
| +43% | +$2.62M | 12.21% | 2 |
|
|
2025
Q1 | $2.71M | Buy |
125,708
+71,235
| +131% | +$1.53M | 3.14% | 11 |
|
|
2024
Q4 | $1.46M | Buy |
+54,473
| New | +$1.46M | 1.47% | 24 |
|
|
2015
Q4 | – | Sell |
-2,956
| Closed | -$752K | – | 54 |
|
|
2015
Q3 | $752K | Sell |
2,956
-3,544
| -55% | -$902K | 0.44% | 45 |
|
|
2015
Q2 | $1.82M | Buy |
+6,500
| New | +$1.82M | 1.13% | 27 |
|